A comprehensive comparison of normalization methods for loading control and variance stabilization of reverse-phase protein array data

Cancer Informatics

Volumn 13, Issue , 2014, Pages 109-117

  Liu, Wenbin ^a   Ju, Zhenlin ^a   Lu, Yiling ^a   Mills, Gordon B ^a   Akbani, Rehan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Normalization; Proteomics; Reverse phase protein array; RPPA

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BIOINFORMATICS; BREAST TUMOR; COMPUTER MODEL; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LOADING CONTROL METHOD; MATHEMATICAL MODEL; PROTEIN MICROARRAY; PROTEOMICS; REVERSE PHASE PROTEIN ARRAY; STATISTICAL ANALYSIS; TOTAL QUALITY MANAGEMENT; VALIDATION PROCESS; VARIANCE STABILIZATION METHOD;

EID: 84908504154     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/CIn.s13329     Document Type: Article

References (21)

1. Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microar-rays which capture disease progression show activation of prosurvival pathways at the cancer invasion front. Oncogene. 2001;20(16):1981–89.
2. Tibes R, Qiu Y, Lu Y, et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ter. 2006;5:2512–21.
3. Liu S, Umezu-Goto M, Murph M, et al. Expression of autotaxin and lysophos-phatidic acid receptors increases mammary tumorigenesis, invasion, and metas-tases. Cancer Cell. 2009;15:539–50.
4. Tsavachidou-Fenner D, Tannir N, Tamboli P, et al. Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma. Ann Oncol. 2010;21(8):1599–606.
5. Hennessy BT, Lu Y, Gonzalez-Angulo AM, et al. A technical assessment of the utility of reverse phase protein arrays for the study of the functional proteome in non-microdissected human breast cancers. Clin Proteomics. 2010;6:129–51.
6. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumors. Nature. 2012;490:61–70.
7. Gonzalez-Angulo AM, Hennessy BT, Meric-Bernstam F, et al. Functional proteomics can defne prognosis and predict pathologic complete response in patients with breast cancer. Clin. Proteomics. 2011;8(1):11.
8. Li J, Lu Y, Akbani R, et al. TCPA: a resource for cancer functional proteomics data. Nat Methods. 2013;10(11):1046–7.
9. Dudoit S, Yang YH, Callow MJ, Speed TP. Statistical methods for identifying diferentially expressed genes in replicated cDNA microarray experiments. Stat Sin. 2002;12(1):111–39.
10. Hu J, He X, Baggerly KA, Coombes KR, Hennessy BT, Mills GB. Non-parametric quantifcation of protein lysate arrays. Bioinformatics. 2007;23(15):1986–94.
11. Neeley ES, Kornbalu SM, Baggery KA. Surface adjustment of reverse phase protein arrays using positive control spots. Cancer Inform. 2011;11:77–86.
12. Neeley ES, Kornblau SM, Coombes KR, Baggerly KA. Variable slope normalization of reverse phase protein arrays. Bioinformatics. 2009;25(11):1384–9.
13. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA. 2001;98:31–6.
14. Pelz CR, Kuesz-Martin M, Bagby G, Sears RC. Global rank-invariant set normalization (GRSN) to reduce systematic distortions in microarray data. BMC Bioinformatics. 2008;9:520.
15. Troncale S, Barbet A, Coulibaly L, et al. NormaCurve: a Supercurve-based method that simultaneously quantifes and normalizes reverse phase protein array data. PLoS One. 2012;7(6):e38686.
16. Birmingham A, Selfors LM, Forster T, et al. Statistical methods for analysis of high-throughput RNA interference screens. Nature Methods. 2009;6:569–75.
17. Efron B, Hastie T, Johnstone I, Tibshirani R. “Least Angle Regression” (with discussion). Ann Stat. 2004;32(2):407–99.
18. Tukey J W. Exploratory Data Analysis. Reading, MA: Addison-Wesley; 1977.
19. Byers LA, Wang J, Nilsson MB, et al. Proteomic profling identifes dysregu-lated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discovery. 2012;2:798–811.
20. Tabus I, Hategan A, Mircean C, et al. Nonlinear modeling of protein expressions in protein arrays. IEEE Trans Signal Process. 2006;54:2394–407.
21. Lin L. A concordance correlation coefcient to evaluate reproducibility. Biometrics. 1989;45:255–68.